Cited by 1273D Printing in Biomedical ResearchLiver Disease Diagnosis and TreatmentLiver physiology and pathology

Liver-on-a-Chip models of fatty liver disease

Open access
Hassan, Shabir, Sebastian, Shikha, Maharjan, Sushila, Lesha, Ami, Carpenter, Anne‐Marie, Liu, Xiuli, Xie, Xin, Livermore, Carol +2 more·2020·Hepatology

Abstract

As a consequence of the obesity epidemic and increasing incidence of metabolic syndrome fatty liver disease now affects a large portion of the world’s population. Left untreated, fatty liver disease can progress to more severe pathologic conditions such as cirrhosis and liver cancer. In an effort to probe the pathophysiology of fatty liver disease and its progression, research over the last decade has led to the engineering of in vitro models of the liver to aid in drug discovery and study of liver pathophysiology. In this review, we discuss advances in modeling liver tissue and the latest developments in understanding disease etiology and treatment from the perspective of engineered in vitro models spanning from conventional planar, static monolayer cultures to those based on the more recently developed bioprinted and liver-on-a-chip platforms. These technologies promise to transform basic biological research, the pharmaceutical industry, and clinical medicine of the liver.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep.31106

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Perfused liver-on-a-chip models can only partially mirror the natural cell organisation in the fatty liver.

    “Some recently engineered perfused liver-on-a-chip models try to overcome these limitations but can only partially mirror the natural cell organisation in the fatty liver.15”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [36]Li D, Wang YL, Xia YN. Electrospinning of polymeric and ceramic nanofibers as uniaxially aligned arrays. Nano Letters 2003; 3: 1167– 1171.
  2. [39]Li D, Babel A, Jenekhe SA, Xia YN. Nanofibers of conjugated polymers prepared by electrospinning with a two-capillary spinneret. Advanced Materials 2004; 16: 2062-+.
  3. [41]Li D, Xia YN. Direct fabrication of composite and ceramic hollow nanofibers by electrospinning. Nano Letters 2004; 4: 933– 938.

Cited by

Sorted by citations

Authors
Hassan, S., Sebastian, S., Maharjan, S., Lesha, A., Carpenter, A., Liu, X., Xie, X., Livermore, C., Zhang, Y. S., & Zarrinpar, A.
Affiliations
  • Brigham and Women's Hospital (US)
  • University of Florida (US)
  • Northeastern University (US)
  • University of Florida Health (US)
Corresponding author
  • Zhang, Yu Shrike
  • Zarrinpar, Ali
Venue
Hepatology
Published
2020-02
Volume
71
Issue
2
Pages
733-740
ISSN
  • 0270-9139 (ISSN-L)
  • 1527-3350
OpenAlex
W2999601492
Cited by
127
References
36
Citations by year
2026: 23 · 2025: 15 · 2024: 22 · 2023: 24 · 2022: 20 · 2021: 18 · 2020: 5
FWCI
1.40
Type
journal article
Language
en
Open access
Locations
  • Hepatology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Brigham Research Institute
  • National Cancer Institute (R00CA201603)
  • National Institute of Diabetes and Digestive and Kidney Diseases (K08DK113244)
  • National Institute of Biomedical Imaging and Bioengineering (R01EB028143, R21EB025270)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords
hepatic steatosis, liver-on-a-chip, in vitro liver models, bioprinting, metabolic syndrome, obesity, liver pathophysiology, drug discovery, liver disease progression, liver cirrhosis, liver cancer
MeSH terms
Fatty Liver, Humans, Models, Structural, Lab-On-A-Chip Devices

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review